Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
ESMO Gastrointestinal Oncology is Scopus-indexed (Q4, CiteScore 0.9), WoS ESCI, DOAJ. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 2949-8198Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Epidemiology | 132 / 173 | 23rd | Q4 |
| Oncology (nursing) | 19 / 24 | 22nd | Q4 |
| Gastroenterology | 139 / 176 | 21st | Q4 |
| Genetics | 333 / 357 | 6th | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2024–present, best quartile Q4, CiteScore 0.9.
ESMO Gastrointestinal Oncology is Q4 in Epidemiology (rank 132 of 173), Q4 in Oncology (nursing) (rank 19 of 24) and Q4 in Gastroenterology (rank 139 of 176), by CiteScore 2025. It is ranked in 4 subject areas in all.
ESMO Gastrointestinal Oncology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 0.9, which places it in quartile Q4 at the 23rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.914, quartile Q1, with an H-index of 6.
The publisher lists an article processing charge of about US$3,170 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
ESMO Gastrointestinal Oncology is published by Elsevier B.V. Its ISSN is 2949-8198.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
ESMO Gastrointestinal Oncology has an h-index of 9 and a 2-year mean of 1.34 citations per paper (OpenAlex). Its Scopus CiteScore is 0.9, quartile Q4. On 2-year citations it ranks #94 of 171 Scopus journals in Epidemiology.
ESMO Gastrointestinal Oncology published 141 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from Japan (21%), United States (10.9%) and Italy (8.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.